Vireo Growth (VREOF) Total Current Liabilities (2020 - 2026)

Vireo Growth (VREOF) reported Total Current Liabilities of $215.8 million for Q1 2026, up 56.77% on a YoY basis from $137.7 million in Q1 2025, and up 12.57% sequentially from $191.7 million in Q4 2025.

Vireo Growth (VREOF) Total Current Liabilities (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Total Current Liabilities data on file, last reported at $215.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities rose 56.77% year-over-year to $215.8 million; the trailing twelve-month figure through Mar 2026 stood at $215.8 million (up 56.77% YoY), and the FY2025 full-year result was $191.7 million, up 41.51% from the prior year.
  • Total Current Liabilities rose to $215.8 million in Q1 2026, from $191.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $243.5 million in Q2 2025 to a low of $18.5 million in Q2 2022.
  • A 5-year average of $138.3 million and a median of $157.0 million in 2023 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities surged 747.46% in 2023 and fell 25.28% in 2025, its largest moves.
  • Tracing VREOF's Total Current Liabilities over 5 years: stood at $29.7 million in 2022, then jumped by 504.09% to $179.5 million in 2023, then decreased by 24.52% to $135.5 million in 2024, then soared by 41.51% to $191.7 million in 2025, then advanced by 12.57% to $215.8 million in 2026.
  • Business Quant data shows VREOF's Total Current Liabilities at $215.8 million in Q1 2026, $191.7 million in Q4 2025, and $234.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 215.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 215.80 Mn
Dec 31, 2025 191.70 Mn
Sep 30, 2025 234.91 Mn
Jun 30, 2025 243.52 Mn
Mar 31, 2025 137.66 Mn
Dec 31, 2024 135.47 Mn
Sep 30, 2024 128.77 Mn
Jun 30, 2024 186.77 Mn
Mar 31, 2024 184.24 Mn
Dec 31, 2023 179.47 Mn
Sep 30, 2023 165.42 Mn
Jun 30, 2023 157.00 Mn
Mar 31, 2023 95.17 Mn
Dec 31, 2022 29.71 Mn
Sep 30, 2022 26.35 Mn
Jun 30, 2022 18.53 Mn
Mar 31, 2022 20.52 Mn
Dec 31, 2021 16.41 Mn
Sep 30, 2021 15.23 Mn
Jun 30, 2021 16.11 Mn